0001053310-22-000003.txt : 20221110 0001053310-22-000003.hdr.sgml : 20221110 20221110183923 ACCESSION NUMBER: 0001053310-22-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221109 FILED AS OF DATE: 20221110 DATE AS OF CHANGE: 20221110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAY E GERALD CENTRAL INDEX KEY: 0001053310 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31668 FILM NUMBER: 221379035 MAIL ADDRESS: STREET 1: C/O 225 LONG AVENUE CITY: HILLSIDE STATE: NJ ZIP: 07205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC CENTRAL INDEX KEY: 0001016504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222407475 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 MAIL ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC DATE OF NAME CHANGE: 20020912 FORMER COMPANY: FORMER CONFORMED NAME: CHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19960716 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-11-09 0 0001016504 INTEGRATED BIOPHARMA INC inbp 0001053310 KAY E GERALD C/O 225 LONG AVENUE HILLSIDE NJ 07205 1 1 1 0 Executive Chairman & President Stock Option (right to buy) 2022-11-09 4 A 0 100000 0 A 2027-11-09 Common Stock 100000 100000 D The Exercise Price of the Stock Option will be 110% the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission. The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023. /s/ E. Gerald Kay 2022-11-10